It is thought that the pitch has been called because of the departure of marketing director George Li, who hired incumbent DMG to handle the brands, in favour of Saatchi & Saatchi. Xian Janssen later shifted three more brands to Ogilvy & Mather, and gave one brand to Draft FCB. Gastrointestinal drug Motilium is Xian Janssen’s top brand, with media spend of Rmb 200 million (US$30 million).
Gyno-Daktarin, a thrush medication, competes against local brands such as Jie Er Yin, Fu Yin Jie and Kang Fu Te - all of which have placed TV at the core of their media strategy.
It is unclear if DMG will defend its hold on the accounts.
Xian Janssen calls for creative pitch
SHANGHAI - Xian Janssen Pharmaceutical is believed to be pitching creative duties for two of its biggest mainland brands - Gyno-Daktarin and Motilium.
